Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that provides VC Investment access to a diverse portfolio of next generation technology companies within an audited, transparent and liquid investment vehicle, is pleased to announce that The Dripbar LLC (“The DRIPBaR”), a partner company (“Partner”) on the Company’s wholly owned subsidiary, VS Digital Health’s (“VSDH”) white labeled software technology platform is now live in the Apple App store and Google Play store. Providing The DRIPBaR patients with a seamless and efficient digital health experience, and to support The DRIPBaR’s growth and franchise potential.

The DRIPBaR is a franchise operator focused on helping people obtain their best physical and mental health using intravenous therapies. Through advances in cellular and biological science, The DRIPBaR helps clients fight the consequences of chronic illness, address the effects of aging, and achieve a balanced wellness. The DRIPBaR aims to make their services accessible throughout the United States, to everyone looking to experience their full suite of vitamin therapy options which include, intramuscular quick shots, lifestyle drops, health support drips and oral supplements. The DRIPBaR is utilizing VSDH’s digital health platform, and digital pharmacy across their 28 active locations, as well as offering their over 430 franchises (at various stages of development) the opportunity to take their medical businesses compliantly mobile, redefining their offering, and helping to meet their fundamental goal of supporting the best health for their clients. The DRIPBaR recently was awarded the Entrepreneur Top 500 List for Top New and Emerging Franchises 2022. (Source Entrepreneur).

This white labeled feature provided by VSDH has allowed The DRIPBaR to take their current brick and mortar business model into the mobile realm. Not only is this exciting for the current locations but it also provides an additional benefit to new franchisees, being the ability to open their businesses and start operating immediately (by utilizing the mobile drip and online pharmacy), while they wait for their physical locations to be built out.

VSDH is tremendously excited to have entered into a long term relationship with one of the top new and emerging health and wellness franchises in the United States (Source Entrepreneur), The DRIPBaR. VSDH will assist in The DRIPBaR’s franchisees in all things digital health, from technology such as our mobile medical app to our digital pharmacy.

VSDH will handle all franchisees’ pharmaceutical orders and streamline not only their processes but offer competitive product offerings and pricing due to VSDH’s unique pharmacy structure across the United States.

Both Companies look forward to working together to assist all DRIPBaR business owners with the expansion of their businesses and at a corporate level continue this meteoric growth.

Further details about the terms and pricing model of The DRIPBaR and VSDH Agreement can be found on release dated March 22, 2022.

About VSDH’s White Labeled Platform

VSDH launched a white-label digital health platform (see press release dated March 7, 2022), that powers consumer health experiences for a wide range of health service providers (from individual practitioners and small boutiques to larger scaled businesses) on a business to business (“B2B”) subscription model, which consists of a fixed annual rate and revenue sharing. This service also includes the setup of a virtual pharmacy facilitating online ordering, payment and processing all in one spot. The business model leverages decentralized healthcare to bring quality digital health (including medical, and health and wellness services) to all 50 states in the U.S., in an efficient, scalable and cost-effective way. 

On behalf of the board,

Shafin Diamond Tejani
Chief Executive Officer
Victory Square Technologies

For further information about the Company, please contact:
Investor Relations Contact – Abbey Vogt
Email: ir@victorysquare.com
Telephone: 604 283-9166
Media Relations Contact – Peter Smyrniotis, Director
Telephone: 604 283-9166

About The DRIPBaR
Founded in 2016 and franchising since late 2019, The DRIPBaR is a franchise focused on helping people obtain their best physical and mental health using intravenous therapies. Through advances in cellular and biological science, The DRIPBaR helps clients fight the consequences of chronic illness, address the effects of aging, and achieve a balanced wellness. With 28 locations currently open and operating, The DRIPBaR already has nearly 430 additional locations in various stages of development across 27 states. For more information, visit www.thedripbar.com.

ABOUT VICTORY SQUARE TECHNOLOGIES INC.
Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed for fast-track growth. Victory Square’s sweet spot is cutting-edge tech that’s shaping the 4th Industrial Revolution. Our corporate portfolio consists of 25 global companies using AI, VR/AR, and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.

What we do differently for startups
Victory Square isn’t your ordinary investor. With real skin in the game, we’re committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you’ll scale and be ready to monetize.

Victory Square is a publicly-traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF). For more information, please visit www.victorysquare.com

Cautionary Disclaimers

All information concerning The DRIPBaR have been provided and approved by their management team. Neither Victory Square nor VSDH have taken any independent verification of any information provided by The DRIPBaR and disclaims any and all liability with respect to any information relating to or provided by The DRIPBaR. The DRIPBaR is an independently operated entity in accordance with applicable laws and neither Victory Square nor VSDH makes any representations or warranties about any products or services provided by The DRIPBaR. The provision of health services is regulated in accordance with applicable laws in each jurisdiction in which The DRIPBaR may operate. Consumers are cautioned to obtain their own legal, health and regulatory advice prior to using any services provided by Victory Square, The DRIPBaR, VSDH, IV Hydreight or resulting from the partnership amongst the parties hereto.

Forward Looking Statement 
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries, including VSDH, IV Hydreight, potential results from the partnership with The DRIPBaR and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up for Our Newsletter

Get the latest investment ideas and strategies sent straight to your inbox.

You May Also Like

Pressure BioSciences Secures Pivotal Cosmeceuticals Partnership for UST Platform With Dr. Denese SkinScience, 20-Year Leader With Over $0.5 Billion in QVC Sales

Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or the “Company”), a leader in the…

First Phosphate Announces Closing of Oversubscribed Private Placement Financing, Buys Out NSR, Initiates 43-101 and Metallurgy work at Lac Orignal, Acquires Additional Land Claims

First Phosphate Corp. (“First Phosphate” or the “Company“) is pleased to announce…

Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine

ENGLEWOOD CLIFFS, NJ, Dec. 01, 2022 (GLOBE NEWSWIRE) — Silo Pharma, Inc. ( Nasdaq: SILO ) (“the…

Regentis Biomaterials Ltd to Become Publicly Listed on Nasdaq via Business Combination with OceanTech Acquisitions I Corp.

NEW YORK & OR-AKIVA, Israel, May 03, 2023–(BUSINESS WIRE)–OceanTech Acquisitions I Corp.,…